KR20240016977A - 2,8-디아자스피로[4.5]데칸 화합물 - Google Patents

2,8-디아자스피로[4.5]데칸 화합물 Download PDF

Info

Publication number
KR20240016977A
KR20240016977A KR1020237042291A KR20237042291A KR20240016977A KR 20240016977 A KR20240016977 A KR 20240016977A KR 1020237042291 A KR1020237042291 A KR 1020237042291A KR 20237042291 A KR20237042291 A KR 20237042291A KR 20240016977 A KR20240016977 A KR 20240016977A
Authority
KR
South Korea
Prior art keywords
alkyl
compound
optionally substituted
independently selected
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237042291A
Other languages
English (en)
Korean (ko)
Inventor
스티븐 존 맥커랄
앨리스 로즈 웡
제임스 존 크라우포드
웬디 리
궝 와 라이
귈라움 펠레티어
스테파니 로이
다나 크리스틴 윈터
미키코 오쿠무라
루트 도렐
Original Assignee
제넨테크, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제넨테크, 인크. filed Critical 제넨테크, 인크.
Publication of KR20240016977A publication Critical patent/KR20240016977A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Pens And Brushes (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
KR1020237042291A 2021-06-04 2022-06-03 2,8-디아자스피로[4.5]데칸 화합물 Pending KR20240016977A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2021098358 2021-06-04
CNPCT/CN2021/098358 2021-06-04
PCT/CN2022/097025 WO2022253341A1 (en) 2021-06-04 2022-06-03 2, 8-diazaspiro [4.5] decane compounds

Publications (1)

Publication Number Publication Date
KR20240016977A true KR20240016977A (ko) 2024-02-06

Family

ID=84322789

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237042291A Pending KR20240016977A (ko) 2021-06-04 2022-06-03 2,8-디아자스피로[4.5]데칸 화합물

Country Status (11)

Country Link
US (1) US20240174696A1 (https=)
EP (1) EP4347594A4 (https=)
JP (1) JP2024521929A (https=)
KR (1) KR20240016977A (https=)
CN (1) CN117425654A (https=)
AR (1) AR126078A1 (https=)
AU (1) AU2022284188A1 (https=)
BR (1) BR112023025393A2 (https=)
CA (1) CA3222054A1 (https=)
TW (1) TW202313608A (https=)
WO (1) WO2022253341A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101679418A (zh) * 2007-04-06 2010-03-24 诺瓦提斯公司 用作蛋白质激酶抑制剂的[2,6]萘啶类化合物
JP2011529932A (ja) * 2008-08-05 2011-12-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換ナフチリジン及び医薬としてのその使用
WO2012167423A1 (en) * 2011-06-08 2012-12-13 Hutchison Medipharma Limited Substituted pyridopyrazines as novel syk inhibitors
KR20140048216A (ko) * 2011-06-29 2014-04-23 오츠카 세이야쿠 가부시키가이샤 치료 화합물로서의 퀴나졸린 및 관련된 사용 방법
TWI675836B (zh) * 2014-03-25 2019-11-01 美商伊格尼塔公司 非典型蛋白質激酶ｃ之氮雜喹唑啉抑制劑
JOP20190257A1 (ar) * 2017-04-28 2019-10-28 Novartis Ag مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats
KR102328435B1 (ko) * 2018-09-11 2021-11-18 재단법인 대구경북첨단의료산업진흥재단 신규 피리도-피리미딘 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 단백질 키나아제 관련 질환의 예방 또는 치료용 약학적 조성물
WO2021050059A1 (en) * 2019-09-11 2021-03-18 Provincial Health Services Authority Dna-pk inhibiting compounds

Also Published As

Publication number Publication date
CN117425654A (zh) 2024-01-19
TW202313608A (zh) 2023-04-01
AU2022284188A1 (en) 2023-11-30
WO2022253341A1 (en) 2022-12-08
AR126078A1 (es) 2023-09-06
EP4347594A1 (en) 2024-04-10
BR112023025393A2 (pt) 2024-02-27
US20240174696A1 (en) 2024-05-30
JP2024521929A (ja) 2024-06-04
EP4347594A4 (en) 2025-06-18
CA3222054A1 (en) 2022-12-08

Similar Documents

Publication Publication Date Title
JP7418395B2 (ja) Ｓｈｐ２ホスファターゼ阻害剤およびこれらの使用方法
TW202321242A (zh) 雜環化合物及使用方法
JP7774709B2 (ja) インターロイキン－１受容体関連キナーゼの二官能性分解剤及びその治療的使用
JP2019108342A (ja) Ｂｔｋ活性阻害剤としてのヘテロアリールピリドン及びアザピリドン化合物
TW202409030A (zh) 五元並六元含氮化物、其中間體、製備方法和應用
MX2012009613A (es) Compuestos de pirrolo-pirimidina como inhibidores de dk4/6.
NZ749946A (en) Novel compound or pharmaceutically acceptable salt thereof
JP7840334B2 (ja) 芳香族複素環式化合物、薬学的組成物、及びその使用
CA3043561C (en) PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
US12435063B2 (en) Nitrogen containing heterocycles as CDK12 inhibitors
EP4303216A1 (en) Fused ring substituted six-membered heterocyclic compound, preparation method therefor and use thereof
CN114144230A (zh) 作为eed和prc2调节剂的大环唑并吡啶衍生物
JP2019530740A (ja) ピリジン並びに５員芳香環系化合物、その製造方法及び使用
US10961238B2 (en) Modulators of hedgehog (Hh) signaling pathway
KR20240052797A (ko) Egfr 억제제로서의 치환된 아미노피리딘 화합물
KR20240016977A (ko) 2,8-디아자스피로[4.5]데칸 화합물
KR20230157467A (ko) 모세혈관 확장성 운동실조증 돌연변이(atm) 키나아제의 선택적 조절제 및 이의 용도
TWI912370B (zh) 芳香雜環類化合物、藥物組合物及其應用
RU2815003C2 (ru) Гетероциклическое соединение
RU2796400C2 (ru) Пиридо[3,4-d]пиримидиновое производное и его фармацевтически приемлемая соль
WO2026024686A1 (en) Kinase modulators and methods of use thereof
HK40101182A (zh) 2,8-二氮杂螺[4.5]癸烷化合物
BR112019010674B1 (pt) Composto, composição farmacêutica, uso de um composto, e, derivado de pirido[3,4-d]pirimidina

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20231207

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250604

Comment text: Request for Examination of Application